Conflicts of interest in clinical research tests are common, and not always disclosed, according to a large national survey of academics on institutional review boards.
The first-of-its-kind review of the boards -- which are charged with making sure patients aren't harmed by experiments -- will likely fuel the debate over how research integrity is affected when clinical investigators have financial ties to companies that pay for testing.
Copyright 2022 NPR. To see more, visit https://www.npr.org. 9(MDAzMjM2NDYzMDEyMzc1Njk5NjAxNzY3OQ001))
